Dismissal Of Texas Dispute Over Restasis Patents Denied
MARSHALL, Texas — Efforts by Mylan Pharmaceuticals Inc. and Mylan Inc. (Mylan, collectively) to dismiss patent infringement allegations stemming from generic Restasis were unsuccessful April 19, when Circuit Judge William C....To view the full article, register now.
Already a subscriber? Click here to view full article